Effects of Interleukin (IL)-4/IL-13 Blockade on the Structure and Function of Cutaneous Sensory Nerves: An Open-label, Single-arm Longitudinal Study With Dupilumab
Latest Information Update: 05 Aug 2022
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis; Eczema
- Focus Therapeutic Use
- 25 Aug 2020 New trial record